Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for ELF2_GABPA_ELF5
Z-value: 1.89
Motif logo
Transcription factors associated with ELF2_GABPA_ELF5
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ELF2
|
ENSG00000109381.20 | ELF2 |
|
GABPA
|
ENSG00000154727.11 | GABPA |
|
ELF5
|
ENSG00000135374.11 | ELF5 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ELF2 | hg38_v1_chr4_-_139084289_139084496 | 0.57 | 1.1e-03 | Click! |
| ELF5 | hg38_v1_chr11_-_34511710_34511799 | 0.54 | 2.3e-03 | Click! |
| GABPA | hg38_v1_chr21_+_25734948_25734988 | 0.04 | 8.1e-01 | Click! |
Activity profile of ELF2_GABPA_ELF5 motif
Sorted Z-values of ELF2_GABPA_ELF5 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ELF2_GABPA_ELF5
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 18.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 2.3 | 16.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.2 | 6.5 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.9 | 7.6 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 1.8 | 3.6 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 1.7 | 1.7 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 1.5 | 5.8 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 1.4 | 4.3 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 1.4 | 4.2 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.3 | 10.2 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.2 | 3.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
| 1.2 | 3.6 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 1.2 | 3.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.2 | 5.8 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.1 | 3.4 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 1.0 | 6.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.9 | 3.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.9 | 2.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.8 | 3.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.8 | 2.4 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.8 | 2.4 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.8 | 2.4 | GO:0006186 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.8 | 3.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 | 3.2 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.8 | 11.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.8 | 4.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.8 | 5.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.7 | 2.2 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.7 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.7 | 1.4 | GO:0000964 | mitochondrial RNA 5'-end processing(GO:0000964) |
| 0.7 | 2.9 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.7 | 5.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.7 | 4.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.7 | 2.7 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.7 | 0.7 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.7 | 4.0 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.7 | 4.0 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 | 6.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.7 | 1.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.6 | 0.6 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.6 | 1.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.6 | 2.6 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.6 | 5.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.6 | 1.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.6 | 3.2 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 0.6 | 3.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.6 | 1.9 | GO:0010932 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.6 | 2.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.6 | 14.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.6 | 2.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.6 | 4.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.6 | 1.8 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.6 | 2.9 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.6 | 4.6 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
| 0.6 | 1.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.6 | 2.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.6 | 3.5 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.6 | 8.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.6 | 1.7 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.6 | 1.7 | GO:0048392 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.6 | 2.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.6 | 3.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.6 | 6.1 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.5 | 1.6 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.5 | 2.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.5 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.5 | 1.0 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.5 | 1.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.5 | 1.5 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.5 | 1.5 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.5 | 10.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.5 | 4.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.5 | 3.5 | GO:0033504 | floor plate development(GO:0033504) |
| 0.5 | 3.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.5 | 2.0 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 | 8.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.5 | 4.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.5 | 8.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.5 | 4.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 | 32.8 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.5 | 1.4 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.5 | 1.9 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 | 1.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.5 | 0.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.5 | 5.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 | 5.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.5 | 0.5 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.5 | 1.8 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.5 | 2.7 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.5 | 1.8 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 0.5 | 1.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.5 | 8.6 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.5 | 2.7 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.5 | 1.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.5 | 1.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.4 | 1.3 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.4 | 5.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 1.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.4 | 2.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 | 1.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.4 | 4.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 1.3 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.4 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.4 | 3.8 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.4 | 1.3 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.4 | 2.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.4 | 4.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.4 | 3.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 | 6.6 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.4 | 6.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.4 | 1.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.4 | 2.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
| 0.4 | 2.0 | GO:2000691 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.4 | 2.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.4 | 19.3 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.4 | 1.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.4 | 3.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.4 | 3.5 | GO:0030242 | pexophagy(GO:0030242) |
| 0.4 | 2.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 | 2.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.4 | 1.9 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.4 | 2.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.4 | 1.5 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.4 | 1.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.4 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.4 | 1.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.4 | 2.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.4 | 2.2 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.4 | 1.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 | 3.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 | 1.7 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.3 | 2.8 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.3 | 1.4 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 | 11.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.3 | 1.0 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 | 2.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.3 | 2.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 | 1.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.3 | 0.3 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
| 0.3 | 0.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) plasma membrane long-chain fatty acid transport(GO:0015911) negative regulation of fatty acid transport(GO:2000192) |
| 0.3 | 1.3 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.3 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.3 | 1.6 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 | 1.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 | 1.0 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.3 | 1.3 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.3 | 1.0 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 | 1.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 | 2.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.3 | 1.6 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 | 2.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 | 2.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 | 1.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.3 | 1.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.3 | 8.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.3 | 1.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.3 | 0.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.3 | 6.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.3 | 1.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.3 | 7.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 0.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 | 0.9 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.3 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.3 | 2.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 | 0.6 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 2.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 | 3.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 1.5 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 1.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 | 1.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 4.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 1.2 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.3 | 1.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.3 | 11.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.3 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 1.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 | 0.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.3 | 0.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.3 | 0.8 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 | 1.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 | 2.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 5.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.3 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.3 | 8.6 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.3 | 2.8 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 | 5.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 | 1.1 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.3 | 2.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.3 | 1.6 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.3 | 1.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 | 4.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 | 0.8 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.3 | 1.1 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 2.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 0.8 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.3 | 1.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.3 | 2.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.3 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.3 | 1.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.3 | 0.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.3 | 1.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 0.5 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.3 | 1.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 | 2.3 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.3 | 1.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 | 2.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.7 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.2 | 0.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 | 1.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.2 | 0.7 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.2 | 1.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.2 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.2 | 1.2 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 | 1.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 | 0.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.2 | 0.7 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.2 | 1.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.2 | 0.2 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.2 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 0.9 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.2 | 0.9 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.2 | 0.7 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 | 0.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.2 | 0.7 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 | 0.9 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 | 0.9 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 0.2 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 0.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 0.9 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.2 | 2.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.2 | 0.6 | GO:0071336 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.2 | 1.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 | 0.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.2 | 1.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.2 | 0.4 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.2 | 0.6 | GO:0006227 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.2 | 2.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 | 0.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.2 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 0.4 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.2 | 0.4 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
| 0.2 | 0.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.2 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 | 1.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.2 | 3.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.2 | 0.8 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.2 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
| 0.2 | 2.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 1.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.2 | 0.8 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.2 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.2 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 2.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 | 0.6 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.2 | 1.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 | 0.6 | GO:0021758 | caudate nucleus development(GO:0021757) putamen development(GO:0021758) |
| 0.2 | 1.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 6.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 | 0.4 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.2 | 2.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 1.0 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.2 | 2.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 1.0 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 0.2 | 1.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.4 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.2 | 2.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 0.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.2 | 1.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 3.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 | 0.6 | GO:0090264 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
| 0.2 | 0.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.2 | 2.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 1.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 0.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.2 | 0.5 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.2 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 1.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.2 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 0.4 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 0.2 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 | 0.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.2 | 2.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 0.5 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.2 | 1.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 2.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 1.0 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) prostate epithelial cord elongation(GO:0060523) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.2 | 1.4 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.2 | 2.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 1.7 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 0.7 | GO:0005985 | sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) |
| 0.2 | 0.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.2 | 0.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.2 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.2 | 0.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 | 2.0 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 | 0.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.2 | 1.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.2 | 0.5 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 | 1.2 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 | 3.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.2 | 4.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.2 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 3.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 | 0.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.2 | 2.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 0.2 | GO:0016074 | snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.2 | 0.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 1.0 | GO:0033087 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 | 0.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.2 | 1.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.2 | 1.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 1.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 1.3 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.2 | 1.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.2 | 0.5 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.2 | 0.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 | 2.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 | 1.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 1.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.2 | 1.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.2 | 3.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 1.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 | 0.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 | 2.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.4 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 | 2.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 1.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 1.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.1 | 0.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.1 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.1 | 0.7 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.1 | 0.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.1 | 0.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.1 | 0.7 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.1 | 0.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.1 | 1.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 1.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 1.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 1.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 0.7 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 1.9 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 | 0.4 | GO:2000706 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.1 | 0.1 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 | 0.6 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 2.7 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
| 0.1 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 | 12.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 3.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 0.6 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 0.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 | 3.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 3.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 2.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 4.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 2.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 8.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 1.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 7.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 6.1 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 0.8 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 3.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 2.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 2.8 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.7 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 | 0.5 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 | 0.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.1 | 0.3 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 | 0.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 1.1 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.5 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 2.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.1 | 0.4 | GO:2000017 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 | 1.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 0.5 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.1 | 0.1 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.1 | 0.4 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.1 | 0.6 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.1 | 2.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 2.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 2.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 1.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 1.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 0.9 | GO:0060013 | righting reflex(GO:0060013) |
| 0.1 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 1.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.1 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 1.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.1 | 1.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.7 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 | 2.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.1 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.5 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
| 0.1 | 0.5 | GO:0018032 | protein amidation(GO:0018032) |
| 0.1 | 5.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 2.3 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.1 | 0.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 0.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 | 0.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 | 1.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 3.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.6 | GO:0019075 | virus maturation(GO:0019075) |
| 0.1 | 2.8 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.2 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 | 0.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.1 | 0.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 | 3.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 3.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.1 | 1.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.1 | 0.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.1 | 3.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.1 | 0.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.1 | 0.8 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 1.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 3.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 0.5 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.1 | 1.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 0.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 1.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 | 0.3 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 0.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.1 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 | 0.8 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.9 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.1 | 3.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.3 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 0.1 | 0.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 1.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.1 | 1.4 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.1 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 0.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 1.0 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.1 | 0.2 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.1 | 0.8 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 0.2 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 0.6 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 0.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 1.6 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.5 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
| 0.1 | 0.6 | GO:0043366 | beta selection(GO:0043366) |
| 0.1 | 0.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 | 0.2 | GO:0044407 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.1 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 1.0 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 2.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 0.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.1 | 0.9 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.1 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.1 | 1.7 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
| 0.1 | 0.7 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.1 | 0.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 0.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 2.1 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.1 | 4.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 2.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 1.0 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.3 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 | 8.6 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 0.1 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
| 0.1 | 0.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 | 0.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 0.7 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 | 15.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
| 0.1 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
| 0.1 | 2.2 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 2.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 0.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.1 | 0.3 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
| 0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 1.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.3 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 2.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 | 7.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.1 | 0.2 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 1.9 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.3 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 | 0.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.1 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 1.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
| 0.1 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 1.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 1.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
| 0.1 | 1.1 | GO:0060004 | reflex(GO:0060004) |
| 0.1 | 0.2 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 0.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 1.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 | 0.3 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.1 | 0.1 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 0.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 | 0.9 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.1 | 0.2 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 1.6 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
| 0.1 | 1.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.1 | 0.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.1 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.1 | 0.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.1 | 1.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.6 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 6.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 2.4 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 0.4 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.1 | 0.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 0.1 | 0.5 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 1.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 0.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 0.3 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 2.7 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.1 | 0.1 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 0.1 | 0.6 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 2.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 | 1.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 0.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 0.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 | 0.2 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 | 0.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.8 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 0.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.1 | 2.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.1 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.1 | 0.2 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 0.1 | 0.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 0.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.1 | 0.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.1 | 0.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.1 | 0.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.1 | 0.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.4 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 2.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.2 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.1 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.1 | 1.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.3 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.1 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.1 | 0.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.1 | 0.4 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 1.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.1 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 1.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.0 | 2.5 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 0.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.0 | 0.2 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.0 | 0.8 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.0 | 0.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 | 0.8 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.0 | 2.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.0 | 0.3 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.0 | 0.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.0 | 1.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.6 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.0 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.0 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.0 | 1.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 | 0.2 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.0 | 0.5 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 0.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.2 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.0 | 0.0 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
| 0.0 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 | 0.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.0 | 0.2 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.0 | 0.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.0 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 | 0.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.0 | 0.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) |
| 0.0 | 2.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.0 | 1.0 | GO:0043967 | histone H4 acetylation(GO:0043967) |
| 0.0 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.0 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 0.1 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.0 | 0.4 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.0 | 0.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.1 | GO:0033590 | response to cobalamin(GO:0033590) |
| 0.0 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.4 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.0 | 0.1 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 | 0.7 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.0 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.0 | 0.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 | 0.4 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.0 | 0.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.0 | 0.1 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.0 | 2.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 0.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 | 1.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.1 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.0 | 0.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.0 | 0.2 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.0 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.0 | 0.4 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.0 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.0 | 0.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.0 | 0.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 | 0.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.0 | 1.0 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.0 | 0.1 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.0 | 0.1 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.0 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.0 | GO:0060534 | trachea cartilage development(GO:0060534) |
| 0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 0.3 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 | 0.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.0 | 0.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.1 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.0 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.0 | 2.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 | 0.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.0 | 0.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 0.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.0 | 0.1 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 | 0.8 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.0 | 0.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.0 | 0.0 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
| 0.0 | 0.1 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.3 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
| 0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.1 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 0.0 | 0.0 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 1.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.0 | 0.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 | 0.0 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 0.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
| 0.0 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.0 | 1.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.0 | 0.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.0 | 0.4 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 0.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.0 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.0 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 0.5 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 | 0.1 | GO:1903976 | peripheral nervous system axon regeneration(GO:0014012) negative regulation of glial cell migration(GO:1903976) |
| 0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.1 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.0 | 0.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
| 0.0 | 0.0 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.0 | 0.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.0 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.0 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 | 0.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.0 | 0.6 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 | 0.0 | GO:0021691 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.0 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 0.2 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 | 0.9 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.0 | 0.0 | GO:0003128 | heart field specification(GO:0003128) secondary heart field specification(GO:0003139) |
| 0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 | 0.0 | GO:0035247 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.0 | 0.0 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 17.8 | GO:0036157 | outer dynein arm(GO:0036157) |
| 1.7 | 5.0 | GO:0001534 | radial spoke(GO:0001534) |
| 1.2 | 5.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.2 | 23.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.1 | 7.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 1.0 | 13.7 | GO:0034464 | BBSome(GO:0034464) |
| 0.9 | 7.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.9 | 10.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.9 | 4.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.8 | 4.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.7 | 17.2 | GO:0036038 | MKS complex(GO:0036038) |
| 0.7 | 2.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.7 | 2.2 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.7 | 2.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.6 | 1.9 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.6 | 3.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.6 | 4.4 | GO:0002177 | manchette(GO:0002177) |
| 0.6 | 7.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.6 | 3.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.6 | 4.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.6 | 4.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.6 | 2.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.6 | 9.5 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.6 | 1.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.6 | 1.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
| 0.6 | 5.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.6 | 2.9 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.5 | 2.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.5 | 1.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.5 | 1.0 | GO:0097545 | axonemal outer doublet(GO:0097545) |
| 0.5 | 3.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.5 | 2.0 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.5 | 5.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.5 | 3.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.5 | 1.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.5 | 2.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.4 | 4.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.4 | 1.7 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.4 | 3.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.4 | 13.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.4 | 4.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.4 | 1.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 3.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 1.2 | GO:0032116 | SMC loading complex(GO:0032116) |
| 0.4 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.4 | 4.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.4 | 1.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.4 | 0.4 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.4 | 1.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.4 | 1.5 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.4 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.4 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.4 | 2.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 2.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.3 | 1.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.3 | 1.3 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.3 | 5.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 3.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 5.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.3 | 1.3 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.3 | 2.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 3.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 0.9 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.3 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.3 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.3 | 3.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.3 | 1.4 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 11.3 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.3 | 1.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.3 | 0.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.3 | 0.3 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.3 | 2.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.3 | 0.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 1.6 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.3 | 1.0 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.3 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 6.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 1.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.2 | 0.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 2.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.2 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 1.9 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.2 | 1.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 1.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 2.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.2 | 0.9 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.2 | 6.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.2 | 0.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.2 | 6.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.2 | 0.9 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 0.9 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.2 | 3.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 3.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 1.3 | GO:0034448 | EGO complex(GO:0034448) |
| 0.2 | 0.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 8.4 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 0.6 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.2 | 4.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
| 0.2 | 1.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 3.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 3.9 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.2 | 1.3 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.2 | 3.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 0.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.2 | 18.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 17.3 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.2 | 1.8 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 6.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 1.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.2 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 0.5 | GO:0071920 | cleavage body(GO:0071920) |
| 0.2 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.2 | 0.8 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.2 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.2 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.2 | 4.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.2 | 2.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 2.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.1 | 5.2 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 2.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 2.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 26.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 1.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 2.6 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 1.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 3.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 2.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.1 | 1.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 8.8 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 1.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 10.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 7.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 4.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.1 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.1 | 10.5 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.2 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
| 0.1 | 0.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 2.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 1.7 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 1.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 4.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 2.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 3.1 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.1 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.7 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 1.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 5.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 7.1 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.5 | GO:0044447 | axoneme part(GO:0044447) |
| 0.1 | 0.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.1 | 1.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 1.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 10.6 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.5 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 4.9 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 0.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.2 | GO:0060987 | lipid tube(GO:0060987) |
| 0.1 | 9.9 | GO:0031514 | motile cilium(GO:0031514) |
| 0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 10.1 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 3.9 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 1.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.2 | GO:0008623 | CHRAC(GO:0008623) |
| 0.1 | 1.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.1 | 3.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 1.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 0.3 | GO:0031673 | H zone(GO:0031673) |
| 0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.0 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 3.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 17.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.1 | GO:0030849 | autosome(GO:0030849) |
| 0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 3.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.1 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 0.0 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.0 | 3.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 1.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 0.1 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.0 | 4.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.1 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.0 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.0 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.0 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 1.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 1.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.0 | 0.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.0 | 0.2 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.0 | 0.1 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.0 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 0.7 | GO:0030286 | dynein complex(GO:0030286) |
| 0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 1.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 2.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.0 | 1.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.0 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
| 0.0 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.0 | 1.1 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.0 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 0.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 2.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.0 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.1 | GO:0070701 | mucus layer(GO:0070701) |
| 0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.0 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.0 | 2.7 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.0 | 0.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.0 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.0 | GO:0038201 | TOR complex(GO:0038201) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 6.1 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 1.8 | 1.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.6 | 6.5 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 1.4 | 4.3 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 1.3 | 4.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.2 | 3.7 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 1.2 | 5.8 | GO:0004803 | transposase activity(GO:0004803) |
| 1.1 | 3.3 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 1.0 | 3.9 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.9 | 8.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.9 | 6.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.9 | 6.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.8 | 2.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.8 | 4.0 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.8 | 4.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.8 | 2.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.8 | 5.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.7 | 2.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.7 | 2.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.7 | 2.6 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.6 | 3.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.6 | 20.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.6 | 1.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.6 | 1.9 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.6 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.6 | 2.4 | GO:0061714 | methotrexate binding(GO:0051870) folic acid receptor activity(GO:0061714) |
| 0.6 | 6.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.6 | 4.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.6 | 1.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.6 | 4.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.6 | 1.7 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.6 | 1.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.6 | 2.8 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.5 | 0.5 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.5 | 1.6 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.5 | 1.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.5 | 8.0 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.5 | 1.6 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.5 | 7.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.5 | 2.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.5 | 4.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.5 | 3.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.5 | 3.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.5 | 3.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.5 | 20.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.5 | 1.5 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.5 | 1.0 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.5 | 2.4 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
| 0.5 | 3.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.5 | 3.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.4 | 1.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.4 | 4.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.4 | 2.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.4 | 13.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.4 | 1.3 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.4 | 2.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.4 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.4 | 1.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.4 | 2.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.4 | 4.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.4 | 5.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 2.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.4 | 3.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.4 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.4 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.4 | 3.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.4 | 2.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.4 | 7.8 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.4 | 2.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.4 | 1.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.4 | 2.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.4 | 4.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.4 | 2.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 3.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.3 | 1.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.3 | 1.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 1.4 | GO:0004040 | amidase activity(GO:0004040) |
| 0.3 | 1.0 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.3 | 1.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.3 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.3 | 1.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 1.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 0.9 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.3 | 1.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.3 | 1.5 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.3 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.3 | 3.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 2.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 1.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.3 | 0.6 | GO:0009041 | thymidylate kinase activity(GO:0004798) uridylate kinase activity(GO:0009041) |
| 0.3 | 2.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.3 | 0.9 | GO:0005135 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
| 0.3 | 10.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.3 | 2.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 2.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.3 | 0.8 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.3 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.3 | 1.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 1.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.3 | 3.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.3 | 0.8 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.3 | 0.8 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.3 | 0.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.3 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.3 | 0.8 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.3 | 3.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.3 | 2.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.3 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.3 | 2.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 1.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.3 | 0.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 5.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 1.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.2 | 2.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.2 | 5.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.2 | 0.2 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
| 0.2 | 5.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 1.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 1.0 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.2 | 0.7 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.2 | 1.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 3.3 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 1.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.2 | 0.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.2 | 3.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.2 | 5.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.2 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 0.9 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.2 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.2 | 4.1 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 2.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.2 | 1.1 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 2.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 1.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 0.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 0.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 0.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.2 | 2.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.2 | 1.8 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 0.9 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.2 | 2.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 0.6 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.2 | 1.3 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 0.9 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.2 | 6.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 0.6 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.2 | 3.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.6 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.2 | 0.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.2 | 1.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 3.0 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.2 | 2.0 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 3.6 | GO:0005537 | mannose binding(GO:0005537) |
| 0.2 | 2.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 0.6 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.2 | 2.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.6 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.2 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.2 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.2 | 4.9 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.2 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 1.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.2 | 1.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.2 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.2 | 0.9 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.2 | 5.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 2.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 2.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 0.5 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.2 | 0.7 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.2 | 0.5 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.2 | 4.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 5.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.2 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.2 | 11.5 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.2 | 9.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.2 | 0.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.2 | 1.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.2 | 3.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 0.7 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 0.5 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.2 | 3.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.2 | 1.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.2 | 0.2 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 0.7 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.2 | 0.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.2 | 0.8 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.2 | 1.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 0.8 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.2 | 0.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.2 | 0.5 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.2 | 0.6 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 0.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.2 | 1.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.2 | 2.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 0.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.2 | 0.5 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.2 | 0.6 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.2 | 1.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.2 | 0.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 2.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.8 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 0.2 | 1.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 1.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 9.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 1.0 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
| 0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 2.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.3 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.1 | 1.0 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 1.0 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 0.4 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.1 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 1.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 2.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 3.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 2.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 3.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.5 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.5 | GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.1 | 2.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 4.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 1.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 2.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.1 | 0.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.1 | 2.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.1 | 2.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 0.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.1 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 2.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 1.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 1.3 | GO:0019864 | IgG binding(GO:0019864) |
| 0.1 | 1.3 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.1 | 1.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.5 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.1 | 1.3 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 1.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 4.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 3.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 7.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 3.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 10.2 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.1 | 2.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 1.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.3 | GO:0035375 | zymogen binding(GO:0035375) |
| 0.1 | 0.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.1 | 1.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 0.3 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.1 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 8.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.1 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 7.5 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
| 0.1 | 0.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 7.0 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.5 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.1 | 1.8 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.1 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.9 | GO:0043559 | insulin binding(GO:0043559) |
| 0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.3 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.1 | 0.7 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 1.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 2.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.3 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
| 0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.1 | 0.5 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.1 | 4.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.7 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 0.8 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 2.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.1 | 3.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 4.8 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 3.0 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 3.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 3.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 2.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 1.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 1.2 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 0.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 2.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 0.2 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.1 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) long-chain-alcohol oxidase activity(GO:0046577) |
| 0.1 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 5.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 1.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.3 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.1 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.3 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 0.1 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 7.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 0.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 0.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 0.1 | 1.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.1 | 1.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 0.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 1.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 0.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 2.9 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.1 | 0.2 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.1 | 0.3 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 0.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.2 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.1 | 0.2 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 2.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 2.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.1 | 3.9 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
| 0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 0.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.2 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 0.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 1.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 2.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 0.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.1 | 0.2 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 5.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 3.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.2 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.0 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.0 | 0.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.0 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.0 | 1.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 1.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 4.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
| 0.0 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.0 | 24.2 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 0.0 | 2.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.0 | 0.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.0 | 1.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.0 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.0 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.0 | 2.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 6.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.0 | 0.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.0 | 4.4 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.0 | 2.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 1.5 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.0 | 1.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
| 0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 1.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.0 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.0 | 0.1 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
| 0.0 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.0 | 0.2 | GO:0097643 | calcitonin family receptor activity(GO:0097642) amylin receptor activity(GO:0097643) |
| 0.0 | 0.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.0 | 0.1 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.0 | 2.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 1.0 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
| 0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.1 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.0 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.2 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) lipopeptide binding(GO:0071723) |
| 0.0 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.0 | 48.9 | GO:0003677 | DNA binding(GO:0003677) |
| 0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.1 | GO:0032557 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) pyrimidine ribonucleotide binding(GO:0032557) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.0 | 1.7 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.0 | 0.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.0 | 0.0 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.0 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.6 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
| 0.0 | 0.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.0 | 0.0 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.0 | 0.0 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.0 | 0.0 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 0.4 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.3 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 4.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.2 | 2.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.2 | 3.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 7.0 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 5.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 7.0 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 11.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 4.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 1.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 7.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 5.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 7.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 9.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 3.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 2.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 0.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 1.2 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 2.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 2.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.0 | 11.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 3.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 2.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.0 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 3.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 2.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 3.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 2.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 1.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 19.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.6 | 15.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 3.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.3 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.3 | 6.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.3 | 4.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.3 | 5.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.3 | 8.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.3 | 6.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 3.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 4.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.2 | 4.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.2 | 5.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.2 | 2.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 2.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 1.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 2.8 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.2 | 6.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 7.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.2 | 3.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.2 | 5.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 5.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 4.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.2 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.2 | 1.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.2 | 5.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.2 | 2.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.2 | 3.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.2 | 11.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.2 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 5.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 3.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.1 | REACTOME SIGNALING BY INSULIN RECEPTOR | Genes involved in Signaling by Insulin receptor |
| 0.1 | 3.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 11.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 5.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 2.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.1 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 0.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 6.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.1 | 3.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 3.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 3.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 1.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 2.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 1.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.1 | 2.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 1.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 1.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 2.1 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.1 | 39.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 1.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 2.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 2.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 0.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 2.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 3.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 2.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 4.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 1.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 9.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 1.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 0.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 3.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 0.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 0.0 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.0 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.0 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 4.0 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 3.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 0.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |